NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM5009208 Query DataSets for GSM5009208
Status Public on May 18, 2021
Title 2_HG24_D6_NegC
Sample type SRA
 
Source name human adipose tissue derived stem cells
Organism Homo sapiens
Characteristics sirna: Negative control
tissue: Adipose tissue
time point: day 6 (mid differentiation)
Treatment protocol Transfection was performed using NEON electroporation system (Invitrogen, Carlsbad, USA). 1600V/20ms pulse and 100μl electroporation tips were used to transfect 106 cells. Final concentration of 20nM siRNA was used (JARID2 siRNA L-009244-00-0010 and non-targeting siRNA D-001810-10-20 from Dharmacon). After electroporation, cells were seeded in a density of 40,000 cells/cm2.
Growth protocol Human mesenchymal stem cells (hMSCs) were isolated from adipose tissue of a male donor (16 years old, BMI 24 kg/m2). Adipose tissue was collagenased and the SVF isolated. The SVF cells were plated in flasks at 3500 cells/cm2 and cultured for 12-14 hours in proliferation medium consisting of low glucose DMEM (Lonza, Verviers, Belgium) supplemented with 10% FBS (Hyclone, Thermo Scientific, Cramlington, UK), penicillin (50 U/ml; Gibco, Life Technologies), streptomycin (50 mg/ml; Gibco, Life Technologies), Hepes (0.5 M) and 2 mmol/l glutamine (Hyclone). The cells were cultured until ~80% confluence, trypsinised and seeded at 4500 cells/cm2 for propagation or at 30 000 cells/cm2 for differentiation. From passage two, FGF2 (5 ng/ml; Sigma-Aldrich) was added to the proliferation medium. The cells were cultured for three days until confluent. FGF2 was then removed from the medium and the cells were incubated for another 24 h. Differentiation medium was prepared by mixing 1:1 of Ham’s F12 (Gibco) and low glucose DMEM supplemented with penicillin (50 U/ml; Gibco, Life Technologies), streptomycin (50 mg/ml; Gibco, Life Technologies), Hepes (0.5 mol/l) and 2 mmol/l glutamine (Sigma- Aldrich). The 1:1 mix was further supplemented with 860 nmol/l insulin, 10 μg/ml transferrin and 0.2 nmol/l triiodothyronine, rosiglitazone (1 μmol/l), IBMX (100 μmol/l) and dexamethasone (1 μmol/l), all from Sigma-Aldrich. The differentiation medium contained 7.8 mmol/l glucose. Differentiation medium was added on day 0 after washing cells twice with PBS. IBMX and dexamethasone were removed after 3 days, and rosiglitazone after 10 days. Full differentiation was reached at day 13. Media were exchanged every 2-3 days.
Extracted molecule total RNA
Extraction protocol Total RNA from hASC was extracted with Nucleospin RNA mini kit from Macherey Nagel (Macherey Nagel, Dueren, Germany)
Illumina TruSeq stranded mRNA sample
The yield and quality of the amplified libraries were analyzed using Qubit (Thermo Fisher) and the Agilent Tapestation (Agilent). The indexed cDNA libraries were normalized, combined and the pools were sequenced on the Illumina Nextseq 550 (Illumina) for a 75-cycle v2 sequencing run generating 75bp single-end reads
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model NextSeq 550
 
Data processing Sample demultiplexing was performed using bcl2fastq (v2.20.0).
Sample quality was assessed using FastQC (v0.11.8) and MultiQC (v1.7).
Reads were aligned to a reference built from Ensembl GRCh38 genome sequences using STAR (v2.6.1d).
Counts for each gene were obtained using featureCounts (v1.5.1) using the GRCh38.99 GTF file from Ensembl
Bioconductor package DESEq2 was used for count normalization and sample group comparisons, generating log2 fold changes, Wald test p-values and p-values adjusted for multiple testing (Benjamini-Hochberg method).
Supplementary_files_format_and_content: raw and normlized counts
 
Submission date Jan 07, 2021
Last update date May 18, 2021
Contact name Jurga Laurencikiene
Organization name Karolinska Institutet
Street address Hälsovägen 7
City Stockholm
ZIP/Postal code 14186
Country Sweden
 
Platform ID GPL21697
Series (1)
GSE164413 RNAseq in JARID2 siRNA-treated in vitro differentiated human primary adipocytes
Relations
BioSample SAMN17252142
SRA SRX9803324

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap